Biomea Fusion, Inc. (BMEA)
NASDAQ: BMEA · Real-Time Price · USD
1.350
0.00 (0.00%)
At close: Dec 18, 2025, 4:00 PM EST
1.340
-0.010 (-0.74%)
Pre-market: Dec 19, 2025, 6:18 AM EST
Biomea Fusion Market Cap
Biomea Fusion has a market cap or net worth of $95.45 million as of December 19, 2025. Its market cap has decreased by -61.66% in one year.
Market Cap
95.45M
Enterprise Value
55.68M
1-Year Change
-61.66%
Ranking
Category
Stock Price
$1.35
Market Cap Chart
Since the IPO on April 16, 2021, Biomea Fusion's market cap has decreased from $489.05M to $95.45M, a decrease of -80.48%. That is a compound annual growth rate of -29.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 18, 2025 | 95.45M | -32.12% |
| Dec 31, 2024 | 140.61M | -72.88% |
| Dec 29, 2023 | 518.45M | 109.21% |
| Dec 30, 2022 | 247.81M | 14.52% |
| Dec 31, 2021 | 216.38M | -55.75% |
| Apr 16, 2021 | 489.05M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 946.31B |
| Johnson & Johnson | 501.88B |
| AbbVie | 393.81B |
| UnitedHealth Group | 297.24B |
| AstraZeneca | 281.41B |
| Novartis AG | 260.53B |
| Merck & Co. | 249.91B |
| Abbott Laboratories | 217.56B |